Grant: Idea to Innovation
University of Ontario Institute of Technology
$121,500.00
A Radiation Triage Mas for Medical Countermeasures, Dosimetry and Risk Estimation
EF 2009-10
Résumé
One of the greatest health risks from terrorist use of a radiological dispersal device (RDD) is from inhalation of radionuclide aerosol particulate after a high energy event (explosive, water or powder release). Additionally, a nuclear facility accident can release quantities of airborne radionuclides under certain accident conditions. Exposure to airborne radionuclides can lead to inhalation, and subsequent uptake of radionuclides into the body. Uptake leads to biological radiation dose and potential health risk. The risk from uptake can be reduced by administering appropriate treatment (such as decorporation therapy). Treatment assumes that (a) it is possible to detect the uptake rapidly, and (b) the radioisotope(s) can be identified, as therapy is element specific. As noted, the appropriate therapeutic treatment regime depends primarily on the rapid identification of the radioisotope involved, however first response personnel (EMS, Fire Fighters, Police, Nurses, etc) do not have the equipment and, more importantly, the expertise to perform rapid radionuclide assessment in the field. Rapid diagnosis is critical as treatment must begin within hours, not days, of exposure in order to ensure the best chance for recovery and risk mitigation. This radiological triage mask (RTM) invention involves development of a half-face mask device with alpha, beta and gamma detectors built into it that, utilizing appropriate hardware processing and software algorithms, can determine the presence of contamination, and also identify the radionuclides present in the orofacial area of a person suspected to have been exposed to airborne contamination. From this, an estimate of the quantity of inhaled material can be made. The mask concept was desirable as it is an ideal geometry for detecting facial contamination, and it is a geometry that is extremely familiar to first response personnel. This technology will be of great benefit to Canada and the World in response to radiological emergencies involving airborne threats.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
385514-2009
Name nom
Waller, Edward
Department département
Energy Systems & Nuclear Science, Faculty of
Organization id
19222
Institution établissement
University of Ontario Institute of Technology
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2009
Award amount
121500
Program id
I2IPJ
Program nane en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
2402
Research subject group en
Nuclear engineering
Research subject group fr
Génie nucléaire
Research subject en
Radioactive materials
Research subject fr
Matériaux radioactifs
Partie
1 & 2
Nb partie
2
Application title
A Radiation Triage Mas for Medical Countermeasures, Dosimetry and Risk Estimation
Keyword
NA
Application summary
One of the greatest health risks from terrorist use of a radiological dispersal device (RDD) is from inhalation of radionuclide aerosol particulate after a high energy event (explosive, water or powder release). Additionally, a nuclear facility accident can release quantities of airborne radionuclides under certain accident conditions. Exposure to airborne radionuclides can lead to inhalation, and subsequent uptake of radionuclides into the body. Uptake leads to biological radiation dose and potential health risk. The risk from uptake can be reduced by administering appropriate treatment (such as decorporation therapy). Treatment assumes that (a) it is possible to detect the uptake rapidly, and (b) the radioisotope(s) can be identified, as therapy is element specific. As noted, the appropriate therapeutic treatment regime depends primarily on the rapid identification of the radioisotope involved, however first response personnel (EMS, Fire Fighters, Police, Nurses, etc) do not have the equipment and, more importantly, the expertise to perform rapid radionuclide assessment in the field. Rapid diagnosis is critical as treatment must begin within hours, not days, of exposure in order to ensure the best chance for recovery and risk mitigation. This radiological triage mask (RTM) invention involves development of a half-face mask device with alpha, beta and gamma detectors built into it that, utilizing appropriate hardware processing and software algorithms, can determine the presence of contamination, and also identify the radionuclides present in the orofacial area of a person suspected to have been exposed to airborne contamination. From this, an estimate of the quantity of inhaled material can be made. The mask concept was desirable as it is an ideal geometry for detecting facial contamination, and it is a geometry that is extremely familiar to first response personnel. This technology will be of great benefit to Canada and the World in response to radiological emergencies involving airborne threats.